LBPS Annual EBITDA
-$76.88 M
-$39.70 M-106.78%
31 December 2021
Summary:
As of February 5, 2025, LBPS annual earnings before interest, taxes, depreciation & amortization is -$76.88 million, with the most recent change of -$39.70 million (-106.78%) on December 31, 2021. During the last 3 years, it has fallen by -$44.30 million (-135.96%).LBPS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LBPS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -106.8% | - | - |
| 3 y3 years | -136.0% | - | - |
| 5 y5 years | -160.2% | - | - |
LBPS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +1962.7% |
4D Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$76.88 M(+106.8%) | - | - |
| Dec 2020 | -$37.18 M(+1.4%) | - | - |
| Dec 2019 | -$36.67 M(+12.6%) | - | - |
| Dec 2018 | -$32.58 M(+10.3%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$29.54 M(+97.9%) | - | - |
| Dec 2016 | -$14.93 M(-0.4%) | - | - |
| Dec 2015 | -$14.99 M(+302.1%) | - | - |
| Dec 2014 | -$3.73 M | - | - |
FAQ
- What is 4D pharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for 4D pharma?
- What is 4D pharma annual EBITDA year-on-year change?
What is 4D pharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of LBPS is -$76.88 M
What is the all time high annual EBITDA for 4D pharma?
4D pharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$3.73 M
What is 4D pharma annual EBITDA year-on-year change?
Over the past year, LBPS annual earnings before interest, taxes, depreciation & amortization has changed by -$39.70 M (-106.78%)